Ocular gene therapy for neovascular AMD: a new era? - Authors' reply.
Saved in:
| Title: | Ocular gene therapy for neovascular AMD: a new era? - Authors' reply. |
|---|---|
| Authors: | Campochiaro PA; Departments of Ophthalmology and Neuroscience, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287-9277, USA. Electronic address: pcampo@jhmi.edu., Heier JS; Ophthalmic Consultants of Boston, Boston, MA, USA., Kherani S; Departments of Ophthalmology and Neuroscience, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287-9277, USA., Le-Halpere A; Sanofi Genzyme, Cambridge, MA, USA., Scaria A; Casebia Therapeutics LLC, Cambridge, MA, USA. |
| Source: | Lancet (London, England) [Lancet] 2017 Nov 11; Vol. 390 (10108), pp. 2140. Date of Electronic Publication: 2017 Nov 09. |
| Publication Type: | Letter; Comment |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
